Abstract:The clinical and experimental results indicated that the T cell immune reconstitution was slow after hematopoietic stem cell transplantation. This study was To analyze the molecular characteristics of T lymphocytic clones during immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation(Allo-HCST)by investigating complementarity determining region (CDR3) repertoires of T cell receptor β chain variable region (TCRVB) and made it possible to understand the relationship between the express of TCRVB and immune reconstitution. Reverse transcriptase-polymerase chain reaction(RT-PCR) amplified 24 subfamily genes of TCRVB from peripheral blood lymphocytes (PBLs) of twenty-four patients with leukemia underwent three kinds of Allo-HSCT(haploidentical bone marrow transplantation, matched sibling bone marrow transplantation and matched-unrelated PBSCT), five normal donors as control. The PCR products were further analyzed by genescane to evaluate the clonality of VB subfamily. The monoclonal bands which associated with GVHD and CMV infection were obtained through denaturation polyacrylamide gel electrophoresis and sequenced. Compared the sequences of TCRVB CDR3 gene repertoire with other sequences associated with GVHD or CMV infection which had been reported. +2~+19months after transplantation, for nine patients among them which underwent haploidentical bone marrow transplantation, there were 6~14 VB subfamilies expressed with 33% 15 VB subfamilies expressed, which 45%of them were polyclones. In the 5 patients of matched-unrelated PBSCT, there were 10~15 VB families expressed, with 45% the polyclone expression. For ten patients underwent matched sibling bone marrow transplantation, 10~16 VB subfamilies expressed and more than 48% were polyclones. Monoclones and oligoclones existed in 24 VB subfamilies, no common monoclone VB subfamilies expressed. According to the usage of VB family and polyclonal expression, Immune reconstitution in patients which underwent haploidentical BMT was later than that of other two groups (p<0.05), there were no different between other two groups (p>0.05). After Allo-HSCT, two patients detected TCRVB in +2m and +3m and found that it has tendency of adding to use VB subfamilies and increasing to express CDR3 polymorphism. Using biology-information tool, compared 23 TCRVB CDR3 molecules which related to GVHD and CMV infection and found that, different cases in the same VB subfamilies may share similarity in amino acid motif, while in different VB subfamilies none of clones appeared to share the same amino acid motif. In 1.5 years after AHSCT, the usage of TCRVB subfamilies still restricted. T-cell immune reconstitution in patients which underwent haploidentical BMT was later than that of other two groups. TCRVB CDR3 molecules which related to GVHD and CMV infection showed that different cases in the same VB subfamilies may share similarity in amino acid motif, while in different VB subfamilies none of clones appeared to share the same amino acid motif.

Reconstitution Kinetics of T Helper Cells Subsets Post Unmanipulated Allogeneic Blood and Marrow Transplantation

[Early Immune Reconstitution after Hematopoietic Stem Cell Transplantation].

Immune Re-Constitution after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Immune Reconstitution Following Unmanipulated HLA-mismatched/haploidentical Transplantation Compared with HLA-identical Sibling Transplantation.

Characteristics of Th9 cell reconstitution after allergenic peripheral blood hematopoietic stem cells transplantation (allo-PBSCT)

Comparison of Immune Reconstitution after Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Transplantation and Unmanipulated HLA-Matched Sibling Transplantation in Patients with Hematological Malignancies.

The Effect of Donor Cd4(+)Cd25(+) Regulatory T Cells on Hematopoietic and Immune Reconstitution, Gvhd and Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation.

Distinct Immune Homeostasis Remodeling Patterns after HLA-Matched and Haploidentical Transplantation

NK Cell Reconstitution Following Unmanipulated HLA-mismatched/haploidentical Transplantation Compared with Matched Sibling Transplantation

Characterization of CD3+CD4−CD8− (double Negative) T Cells Reconstitution in Patients Following Hematopoietic Stem-Cell Transplantation

The Molecular Characteristics of T-cell Immune Reconstitution in Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Conflicting impact of alloreactive NK cells on transplantation outcomes after haploidentical transplantation: do the reconstitution kinetics of natural killer cells create these differences?

[Comparative Analysis of Naive and Memory CD4(+) and CD8(+) T-cell Subsets in Rhg-Csf Mobilized Peripheral Blood and Steady-State Bone Marrow].

Difference in Bone Marrow Morphology among Different Allogeneic Transplantations in Patients with Acute Leukemia

[Reconstitution Dynamics of Plasmacytoid and Myeloid Dendritic Cell Precursors after Allogeneic HLA Mismatched/ Haploidentical Hematopoietic Stem Cell Transplantation].

The CD4+CD25highregulatory T Cell Reconstitution after Allogenetic Stem Cell Transplantation and Its Correlations with aGVHD

[Comparison of Immune Reconstitution at Early Stage after Unmanipulated Haploidentical Stem Cell Transplantation Between High- and Standard- Risk Philadelphia Chromosome- Negative Acute Lymphoblastic Leukemia Patients in CR1].

Patterns of T-Cell Reconstitution by Assessment of T-Cell Receptor Excision Circle and T-Cell Receptor Clonal Repertoire after Allogeneic Hematopoietic Stem Cell Transplantation in Leukemia Patients - A Study in Chinese Patients

[Comparative Analysis of Early Reconstitution of T-lymphocyte Subsets and T-cell Receptor Excision Cycles in Patients after Myeloablative Unrelated Cord Blood and Sibling Donor Transplantation].

Decrease of Cd4(+)Cd25(+) Regulatory T Cells and Tgf-Beta at Early Immune Reconstitution is Associated to the Onset and Severity of Graft-Versus-Host Disease Following Allogeneic Haematogenesis Stem Cell Transplantation

A Comparison of Clinical Characteristics and Prognosis of Adult Acute Graft-Versus-host Disease Between Human Leukocyte Antigen-Identical And-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation